Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
about
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancerThe sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissueMicroarray analysis of genes associated with cell surface NIS protein levels in breast cancerSodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells.Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene deliveryImage-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.TRPM7 is regulated by halides through its kinase domainThe sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells.The biology of the sodium iodide symporter and its potential for targeted gene delivery.Genetics and phenomics of hypothyroidism and goiter due to NIS mutations.Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene.Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines.A novel method of boron delivery using sodium iodide symporter for boron neutron capture therapy
P2860
Q33603806-41FCB26A-8611-4DE9-AF6D-5814893F6245Q33808557-43085B07-E28D-4A3C-8872-452BBD1B64D7Q34046672-BA084F12-DD55-40C5-996D-EC7781A3C95CQ34303955-6AC18EFA-8F69-48E2-98BB-73D7B596A5B4Q34578515-1B0EF12A-53E6-4FD9-933E-DE36B74ACD08Q35238289-D3EE92FD-15AA-4602-B858-1050F1EB1A3EQ35612571-846A6AE2-DCC0-4EB9-A1E4-A72BC65FDA7BQ36128415-9BD22D50-0C66-489C-BB73-25705CDC2D7DQ36720696-8E20D415-479E-4678-9CD1-292141A1627DQ37008898-C6CC4451-6539-49A6-A605-DF310C8CD881Q37211959-17E5EFBE-4B90-4453-9EF2-9A5A6935BA7EQ37564872-FEBCF56E-D5DD-4947-AD22-4C02ACBCD9CEQ37691930-3096F734-2294-41BF-88C0-585752394A1FQ38772380-01F74E08-48EE-4EDC-92DD-2197AEA2B1D8Q39793097-E93AB0B9-1700-4EB7-BE44-952A2410145DQ39830722-1396CE6C-DE9B-4DF3-BDEC-B9EC293E300A
P2860
Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Functional sodium iodide sympo ...... tinoic acid and dexamethasone.
@en
type
label
Functional sodium iodide sympo ...... tinoic acid and dexamethasone.
@en
prefLabel
Functional sodium iodide sympo ...... tinoic acid and dexamethasone.
@en
P2093
P1476
Functional sodium iodide sympo ...... tinoic acid and dexamethasone.
@en
P2093
Bibi Sharif-Samani
Burkhard Göke
Christine Spitzweg
John C Morris
Michael J Willhauck
Nathalie Wunderlich
Reingard Senekowitsch-Schmidtke
P2860
P2888
P304
P356
10.1007/S10549-007-9646-0
P407
P577
2007-07-18T00:00:00Z
P6179
1039394033